189 related articles for article (PubMed ID: 34382466)
1. Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.
Adane T; Getawa S
J Int Med Res; 2021 Aug; 49(8):3000605211034656. PubMed ID: 34382466
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil.
Souza MA; Passos AM; Treitinger A; Spada C
Rev Soc Bras Med Trop; 2010; 43(4):359-61. PubMed ID: 20802930
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
Das B; Kaur G; Basu S
Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
[TBL] [Abstract][Full Text] [Related]
5. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.
Fowler K; Mucha J; Neumann M; Lewandowski W; Kaczanowska M; Grys M; Schmidt E; Natenshon A; Talarico C; Buck PO; Diaz-Decaro J
BMC Public Health; 2022 Sep; 22(1):1659. PubMed ID: 36050659
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of transfusion-transmitted infections in hospitalized patients before transfusion and volunteer blood donors in Zhejiang Province, China.
Mengjiao L; Yushan X; Yan L; Dawei C; Xiaojun Z; Yongjun W; Cuifen S; Jue X
Infect Dis Now; 2024 Mar; 54(2):104861. PubMed ID: 38316362
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Cytomegalovirus antibodies and primary infection among hemodialysis patients: A systematic and meta-analysis review.
Mesgar Saravi N; Mousavi T
Transpl Immunol; 2022 Jun; 72():101587. PubMed ID: 35339658
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
[TBL] [Abstract][Full Text] [Related]
10. Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014.
Bawa MK; Mamman A; Olayinka A; Gidado S; Waziri NE; Balogun MS; Getso KI; Dalhat MM; Nsubuga P; Aliyu N; Bala H; Muhammad H; Haladu S; Shehu UL; Nguku PM
Pan Afr Med J; 2019; 32(Suppl 1):6. PubMed ID: 30984327
[TBL] [Abstract][Full Text] [Related]
11. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
Voruz S; Gowland P; Eyer C; Widmer N; Abonnenc M; Prudent M; Masouridi-Levrat S; Duchosal MA; Niederhauser C
Blood Transfus; 2020 Nov; 18(6):446-453. PubMed ID: 32203012
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis.
Zuhair M; Smit GSA; Wallis G; Jabbar F; Smith C; Devleesschauwer B; Griffiths P
Rev Med Virol; 2019 May; 29(3):e2034. PubMed ID: 30706584
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.
Furui Y; Satake M; Hoshi Y; Uchida S; Suzuki K; Tadokoro K
Transfusion; 2013 Oct; 53(10):2190-7. PubMed ID: 23968359
[TBL] [Abstract][Full Text] [Related]
15. The seroprevalence of cytomegalovirus antibodies among prospective blood donors in Jos.
Alao OO; Joseph DE; Mamman A; Banwat EB
Niger J Med; 2008; 17(2):198-200. PubMed ID: 18686839
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
17. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
[TBL] [Abstract][Full Text] [Related]
18. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of cytomegalovirus infection in Mauritian volunteer blood donors.
Pultoo A; Meetoo G; Pyndiah MN; Khittoo G
Indian J Med Sci; 2001 Feb; 55(2):73-8. PubMed ID: 11482160
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq.
Aljumaili ZK; Alsamarai AM; Najem WS
J Infect Public Health; 2014; 7(4):277-88. PubMed ID: 24629348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
